Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus

por Dahal, Lekh N., Basu, Neil, Youssef, Hazem, Khanolkar, Rahul C., Barker, Robert N., Erwig, Lars P., Ward, Frank J.
Publicado 2016

TGFβ2 Induces the Soluble Isoform of CTLA-4 – Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant Melanoma

por Khanolkar, Rahul C., Zhang, Chu, Al-Fatyan, Farah, Lawson, Linda, Depasquale, Ivan, Meredith, Fiona M., Muller, Frank, Nicolson, Marianne, Dahal, Lekh Nath, Abu-Eid, Rasha, Rajpara, Sanjay, Barker, Robert Norman, Ormerod, Anthony D., Ward, Frank James
Publicado 2022